Delivery Order SPE2DB22D1106-SPE2DB25FEZK8
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,132.74 order is for the supply of 4,563,436,037 OxyContin ER 15 mg tablets to support Defense Logistics Agency Troop Support Medical operations. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $1,941.60 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of OxyContin ER 15 mg tablets in quantities of 100 units. This firm fixed-price delivery order, which is a child contract under a larger vehicle, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,556.63 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OxyContin ER 20 mg tablets. The contract has a completion date of February 20, 2024 and was awarded on February 16, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is a for-profit organization. This delivery order is part of a larger indefinite delivery contract (IDC) valued at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of OxyContin tablets 40mg, with a contract ceiling value of $2,508.63 and an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,215.82, represents a non-competitive set-aside contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,184.84 and is structured as a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,009.06 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,157.61, is for the delivery of OxyContin ER 20 mg tablets. It is a firm fixed-price contract with an ultimate completion date of July 3, 2025. The contract is not set aside and was awarded on July 2, 2025. AmerisourceBergen Drug Corporation holds a significant Indefinite...
- This is a $1,734.97 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OxyContin ER 20 mg tablets, a prescription pain medication. The contract has an ultimate completion date of June 24, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZK8Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,161.00 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of OxyContin ER 15 mg tablets (100-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical supply chain, serving critical procurement needs for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capacity to fulfill competitive procurement requirements across multiple therapeutic domains, including pain management pharmaceuticals, specialty medications, and controlled substances such as this OxyContin delivery. This particular delivery order represents routine pharmaceutical resupply operations supporting the Defense Health Agency and broader Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/24/25 |